Carsten Deppermann

Prof. Carsten Deppermann


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MMMohsen Malehmir
Mohsen Malehmir
DPDominik Pfister
Dominik Pfister
SGSuchira Gallage
Suchira Gallage
MSMarta Szydlowska
Marta Szydlowska
DIDonato Inverso
Donato Inverso
MHMathias Heikenwälder
Mathias Heikenwälder

Verified
Journal Article
Open access
PDF file
JMJonathan Tarik Mandel
Jonathan Tarik Mandel
MCMartina Casari
Martina Casari
MSMaria Stepanyan
Maria Stepanyan
AMAlexey Martyanov
Alexey Martyanov
CDCarsten Deppermann
Carsten Deppermann
There is accumulating evidence that platelets play roles beyond their traditional functions in thrombosis and hemostasis, e.g., in inflammatory processes, infection and cancer, and that they interact, stimulate and regulate cells of the innate immune system such as neutrophils, monocytes and macrophages. In this review, we will focus on platelet activation in hemostatic and inflammatory processes, as well as platelet interactions with neutrophils and monocytes/macrophages. We take a closer look at the contributions of major platelet receptors GPIb, αIIbβ3, TLT-1, CLEC-2 and Toll-like receptors (TLRs) as well as secretions from platelet granules on platelet–neutrophil aggregate and neutrophil extracellular trap (NET) formation in atherosclerosis, transfusion-related acute lung injury (TRALI) and COVID-19. Further, we will address platelet–monocyte and macrophage interactions during cancer metastasis, infection, sepsis and platelet clearance.

1 July 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CDCarsten Deppermann
Carsten Deppermann
DCDeya Cherpokova
Deya Cherpokova
PNPaquita Nurden
Paquita Nurden
JSJan-Niklas Schulz
Jan-Niklas Schulz
ITIna Thielmann
Ina Thielmann
BNBernhard Nieswandt
Bernhard Nieswandt
Platelets are anuclear organelle-rich cell fragments derived from bone marrow megakaryocytes (MKs) that safeguard vascular integrity. The major platelet organelles, α-granules, release proteins that participate in thrombus formation and hemostasis. Proteins stored in α-granules are also thought to play a role in inflammation and wound healing, but their functional significance in vivo is unknown. Mutations in NBEAL2 have been linked to gray platelet syndrome (GPS), a rare bleeding disorder characterized by macrothrombocytopenia, with platelets lacking α-granules. Here we show that Nbeal2-knockout mice display the characteristics of human GPS, with defective α-granule biogenesis in MKs and their absence from platelets. Nbeal2 deficiency did not affect MK differentiation and proplatelet formation in vitro or platelet life span in vivo. Nbeal2-deficient platelets displayed impaired adhesion, aggregation, and coagulant activity ex vivo that translated into defective arterial thrombus formation and protection from thrombo-inflammatory brain infarction following focal cerebral ischemia. In a model of excisional skin wound repair, Nbeal2-deficient mice exhibited impaired development of functional granulation tissue due to severely reduced differentiation of myofibroblasts in the absence of α-granule secretion. This study demonstrates that platelet α-granule constituents are critically required not only for hemostasis but also thrombosis, acute thrombo-inflammatory disease states, and tissue reconstitution after injury.

1 November 2013 in Stroke
Verified
Journal Article
Closed access
PDF file
PKPeter Kraft
Peter Kraft
EGEva Göb
Eva Göb
MSMichael K. Schuhmann
Michael K. Schuhmann
KGKerstin Göbel
Kerstin Göbel
CDCarsten Deppermann
Carsten Deppermann
Christoph KleinschnitzChristoph Kleinschnitz
Christoph Kleinschnitz
Background and Purpose—: Lymphocytes are important players in the pathophysiology of acute ischemic stroke. The interaction of lymphocytes with endothelial cells and platelets, termed thrombo-inflammation, fosters microvascular dysfunction and secondary infarct growth. FTY720, a sphingosine-1-phosphate receptor modulator, blocks the egress of lymphocytes from lymphoid organs and has been shown to reduce ischemic neurodegeneration; however, the underlying mechanisms are unclear. We investigated the mode of FTY720 action in models of cerebral ischemia. Methods—: Transient middle cerebral artery occlusion (tMCAO) was induced in wild-type and lymphocyte-deficient Rag1 −/− mice treated with FTY720 (1 mg/kg) or vehicle immediately before reperfusion. Stroke outcome was assessed 24 hours later. Immune cells in the blood and brain were counted by flow cytometry. The integrity of the blood–brain barrier was analyzed using Evans Blue dye. Thrombus formation was determined by immunohistochemistry and Western blot, and was correlated with cerebral perfusion. Results—: FTY720 significantly reduced stroke size and improved functional outcome in wild-type mice on day 1 and day 3 after transient middle cerebral artery occlusion. This protective effect was lost in lymphocyte-deficient Rag1 −/− mice and in cultured neurons subjected to hypoxia. Less lymphocytes were present in the cerebral vasculature of FTY720-treated wild-type mice, which in turn reduced thrombosis and increased cerebral perfusion. In contrast, FTY720 was unable to prevent blood–brain barrier breakdown and transendothelial immune cell trafficking after transient middle cerebral artery occlusion. Conclusions—: Induction of lymphocytopenia and concomitant reduction of microvascular thrombosis are key modes of FTY720 action in stroke. In contrast, our findings in Rag1 −/− mice and cultured neurons argue against direct neuroprotective effects of FTY720.

5 March 2021 in Science
Verified
Journal Article
Closed access
PDF file
JZJ. Zindel
J. Zindel
MPMoritz Peiseler
Moritz Peiseler
MHMokarram Hossain
Mokarram Hossain
CDCarsten Deppermann
Carsten Deppermann
WLW. Y. Lee
W. Y. Lee
PKP. Kubes
P. Kubes
Macrophages seal 'em in the coelom: GATA6 + macrophages resident in body cavities exhibit both phagocytic and repair functions. However, the mechanisms by which these cells can identify and migrate to sites of injury have remained unclear. Using intravital imaging of mouse peritoneal cavities, Zindel et al. report that GATA6 + macrophages rapidly assemble clot-like structures in a process strongly analogous to thrombosis (see the Perspective by Herrick and Allen). The formation of these aggregates requires the expression of macrophage scavenger receptor domains and acts to plug wounds and promote healing. This pathway can be inadvertently activated during medical procedures, when macrophage aggregates can promote the generation of abdominal scar tissue known as adhesions. Inhibition of macrophage scavenger receptors may therefore be a useful therapeutic approach after surgeries that cause injury to body cavities. Science , this issue p. eabe0595 ; see also p. 993

8 September 2020 in Platelets
Verified
Journal Article
Closed access
KMKimberly Martinod
Kimberly Martinod
CDCarsten Deppermann
Carsten Deppermann
Platelets are increasingly being recognized for playing roles beyond thrombosis and hemostasis. Today we know that they mediate inflammation by direct interactions with innate immune cells or secretion of cytokines/chemokines. Here we review their interactions with neutrophils and monocytes/macrophages in infection and sepsis, stroke, myocardial infarction and venous thromboembolism. We discuss new roles for platelet surface receptors like GPVI or GPIb and also look at platelet contributions to the formation of neutrophil extracellular traps (NETs) as well as to deep vein thrombosis during infection, e.g. in COVID-19 patients.